AWHL insider buying and SEC filings, explained
Aspira Women's Health Inc. · CIK 926617
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- OTC
- Industry (SIC)
- In Vitro & In Vivo Diagnostic Substances
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- VERMILLION, INC.; CIPHERGEN BIOSYSTEMS INC
Insider activity in the last 12 months
Bought
$125K
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 5, 2026 | Other purchase | Jack W. Schuler (10% owner) bought 300,000 Warrant (Right to Buy) indirectly (by trust) at $0.0000 ($0), reported as a purchase (code P). New position of 300,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 9, 2026 |
| Jun 5, 2026 | Purchase (code P) | Jack W. Schuler (10% owner) bought 222,222 shares indirectly (by trust) at $0.4500 ($100K), reported as a purchase (code P). Holdings by trust up 6% to 4,046,051 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 9, 2026 |
| Sep 17, 2025 | Other purchase Amended filing | John D Fraser (Director) bought 12,292 Warrant (Right to Buy) at $0.0000 ($0), reported as a purchase (code P). New position of 12,292 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Sep 19, 2025. | SEC filing Filed May 29, 2026 |
| Sep 17, 2025 | Purchase (code P) Amended filing | John D Fraser (Director) bought 16,389 shares at $0.4500 ($7K), reported as a purchase (code P). Holdings up 3% to 566,393 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Sep 19, 2025. | SEC filing Filed May 29, 2026 |
| Sep 17, 2025 | Other purchase Amended filing | Jeffrey k cohen (Director) bought 41,667 Warrant (Right to Buy) at $0.0000 ($0), reported as a purchase (code P). New position of 41,667 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Sep 19, 2025. | SEC filing Filed May 29, 2026 |
| Sep 17, 2025 | Purchase (code P) Amended filing | Jeffrey k cohen (Director) bought 55,556 shares at $0.4500 ($25K), reported as a purchase (code P). Holdings up 17% to 374,906 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Sep 19, 2025. | SEC filing Filed May 29, 2026 |
9 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AWHL in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.